Surviving sepsis campaign in Brazil

Shock

Volumn 30, Issue SUPPL. 1, 2008, Pages 47-52

  Teles, José Mário Meira ^a,b,f   Silva, Eliezer ^b   Westphal, Glauco ^b,c   Costa Filho, Rubens ^b,d   Machado, Flavia Ribeiro ^b,e  

^a Hospital Portugues   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Hospital Municipal Sao Jose   (Brazil)

^d HOSPITAL PRÓ CARDÍACO   (Brazil)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^f NONE   (Brazil)

Author keywords

Bundles; Guidelines; Sepsis; Septic shock; Treatment

Indexed keywords

BRAZIL; CONFERENCE PAPER; DISEASE SEVERITY; FOLLOW UP; HEALTH PROGRAM; HEALTH SERVICE; HOSPITALIZATION; HUMAN; MEDICAL SOCIETY; MORTALITY; RISK FACTOR; SEPSIS; SEPTIC SHOCK;

EID: 54049105295     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318181a128     Document Type: Conference Paper

References (23)

1. Silva E, Akamine N, Salomao R, Townsend SR, Dellinger RP, Levy M: Surviving Sepsis Campaign: a project to change sepsis trajectory. Endocr Metab Immune Disord Drug Targets 6:217-222, 2006.
2. Martin GS, Mannino DM, Eaton S, Moss M: Epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546-1554, 2003.
3. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310, 2001.
4. Hoyert DL, Anderson RN: Age-adjusted death rates: trend data based on the year 2000 standard population. Natl Vital Stat Rep 49:1-6, 2001.
5. Friedman G, Silva E, Vincent JL: Has the mortality of septic shock changed with time? Crit Care Med 26:2078-2086, 1998.
6. Silva E, Pedro MA, Sogayar AC, Mohovic T, Silva CL, Janiszewski M, Cal RG, de Sousa EF, Abe TP, de Andrade J, et al., Brazilian Sepsis Epidemiological Study: Brazilian Sepsis Epidemiological Study (BASES study). Crit Care 8:251-260, 2004.
7. Opal SM: Clinical trial design and outcomes in patients with severe sepsis. Shock 20:295-302, 2003.
8. Marshall JC, Deitch C, Moldawer LL, Opal S, Redl H, Van der Poll T: Preclinical models of shock and sepsis: what can their tells us? Shock 24:1-6, 2005.
9. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377, 2001.
10. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, et al.: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589-1596, 2006.
11. Vincent JL, Bernard GR, Beale R, Doig C, Putensen C, Dhainaut JF, Artigas A, Fumagalli R, Macias W, Wright T, et al.: Further evidence for survival and safety and implications for early treatment. Crit Care Med 33:2266-2277, 2005.
12. Lee H, Doig CJ, Ghali WA, Donaldson C, Johnson D, Manns B: Detailed cost analysis of care for survivors of severe sepsis. Crit Care Med 32:981-985, 2004.
13. Latin American Sepsis Institute: Campanha sobrevivendo a sepse. Available at: http://www.sepsisnet.org/site/conteudo/SSCUH.pdf.
14. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, et al., Surviving Sepsis Campaign Management Guidelines Committee: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858-873, 2004.
15. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, et al., Surviving Sepsis Campaign Management Guidelines Committee: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 30:536-555, 2004.
16. Sales JA Jr, David CM, Hatum R: Sepse Brasil: estudo epidemioló gico da sepse em unidades de terapia intensiva brasileiras. RBTI 18:9-17, 2006.
17. Beale R, Reinhart K, Dobb G, Silva E, LeClerc J, Basson B, Angus D: PROGRESS (Promoting Global Research Excellence in Severe Sepsis): a preliminary report of an international Internet-based sepsis registry. Chest 124:224, 2003.
18. Sogayar AMC, Machado FR, Rea-Neto A, Dornas A, Grion C, Lobo SM, Tura B, Silva CLO, Cal RGR, Beer I, et al., for the Costs Study Group-Latin American Sepsis Institute: COSTS - multicenter, prospective study to evaluate costs of septic patients in Brazilian intensive care units. Pharmacoeconomics 26:425-434, 2008.
19. Berenholtz S, Provonost PJ: Barriers to translate evidence into practices. Curr Opin Crit Care 9:321-325, 2003.
20. Eichacker PQ, Natanson C, Danner RL: Surviving sepsis-practice guidelines, marketing campaigns, and Eli Lilly. N Engl J Med 355(16):1640-1642, 2006.
21. Fletcher SJ, Quinn AC: The Surviving Sepsis Campaign and sepsis care bundles: substance or sophistry? Anaesthesia 61:313-315, 2006.
22. Eichacker PQ, Natanson C, Danner RL: Separating practice guidelines from pharmaceutical marketing. Crit Care Med 35:2877-2878, 2007.
23. Machado FR, Freitas F: Controversies in surviving sepsis campaign bundles: should we use them? Shock 30(suppl 1):34-40, 2008.